BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29376949)

  • 1. The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas.
    Kirkland TN
    J Fungi (Basel); 2016 Dec; 2(4):. PubMed ID: 29376949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Population Structure and Patterns of Western Hemisphere Dispersal for Coccidioides spp., the Fungal Cause of Valley Fever.
    Engelthaler DM; Roe CC; Hepp CM; Teixeira M; Driebe EM; Schupp JM; Gade L; Waddell V; Komatsu K; Arathoon E; Logemann H; Thompson GR; Chiller T; Barker B; Keim P; Litvintseva AP
    mBio; 2016 Apr; 7(2):e00550-16. PubMed ID: 27118594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rise of
    Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
    Front Immunol; 2019; 10():2188. PubMed ID: 31572393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PM10 and Other Climatic Variables Are Important Predictors of Seasonal Variability of Coccidioidomycosis in Arizona.
    Kollath DR; Mihaljevic JR; Barker BM
    Microbiol Spectr; 2022 Apr; 10(2):e0148321. PubMed ID: 35319247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and outcomes of culture-proven acute Coccidioides spp. infection in San Diego, California, United States.
    Jenks JD; Reed SL; Hoenigl M
    Mycoses; 2020 Jun; 63(6):553-557. PubMed ID: 32176829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life Cycle Dominates the Volatilome Character of Dimorphic Fungus
    Higgins Keppler EA; Mead HL; Barker BM; Bean HD
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in Coccidioidomycosis - California, 2000-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(5):105-9. PubMed ID: 19214158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development.
    Hernandez H; Erives VH; Martinez LR
    Curr Trop Med Rep; 2019 Sep; 6(3):132-144. PubMed ID: 34367879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Chronic Coccidioidomycosis in Mice.
    Shubitz LF; Butkiewicz CD; Trinh HT
    Methods Mol Biol; 2023; 2667():139-158. PubMed ID: 37145282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Structure and Genetic Diversity among Isolates of
    Teixeira MM; Alvarado P; Roe CC; Thompson GR; Patané JSL; Sahl JW; Keim P; Galgiani JN; Litvintseva AP; Matute DR; Barker BM
    mBio; 2019 Nov; 10(6):. PubMed ID: 31772050
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigating the Relationship Between Climate and Valley Fever (Coccidioidomycosis).
    Weaver EA; Kolivras KN
    Ecohealth; 2018 Dec; 15(4):840-852. PubMed ID: 30284073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mysterious desert dwellers: Coccidioides immitis and Coccidioides posadasii, causative fungal agents of coccidioidomycosis.
    Kollath DR; Miller KJ; Barker BM
    Virulence; 2019 Dec; 10(1):222-233. PubMed ID: 30898028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the Epidemiology, Diagnosis, and Treatment of Coccidioidomycosis.
    Williams SL; Chiller T
    J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of innate and adaptive immunity to coccidioidomycosis.
    Hung CY; Hsu AP; Holland SM; Fierer J
    Med Mycol; 2019 Feb; 57(Supplement_1):S85-S92. PubMed ID: 30690602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.
    Kirkland TN; Fierer J
    Virulence; 2018; 9(1):1426-1435. PubMed ID: 30179067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valley Fever on the Rise-Searching for Microbial Antagonists to the Fungal Pathogen
    Lauer A; Baal JD; Mendes SD; Casimiro KN; Passaglia AK; Valenzuela AH; Guibert G
    Microorganisms; 2019 Jan; 7(2):. PubMed ID: 30682831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coccidioidomycosis in Northern Arizona: an Investigation of the Host, Pathogen, and Environment Using a Disease Triangle Approach.
    Mead HL; Kollath DR; Teixeira MM; Roe CC; Plude C; Nandurkar N; Donohoo C; O'Connor BLW; Terriquez J; Keim P; Barker BM
    mSphere; 2022 Oct; 7(5):e0035222. PubMed ID: 35972134
    [No Abstract]   [Full Text] [Related]  

  • 19. Real-time PCR assay for detection and differentiation of Coccidioides immitis and Coccidioides posadasii from culture and clinical specimens.
    Chaturvedi S; Victor TR; Marathe A; Sidamonidze K; Crucillo KL; Chaturvedi V
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009765. PubMed ID: 34529679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.
    Krogstad P; Johnson R; Garcia-Lloret MI; Heidari A; Butte MJ
    Clin Ther; 2019 Oct; 41(10):1939-1954.e1. PubMed ID: 31648806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.